Tokyo, Oct. 5 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063160) titled 'Physician and Patient Preferences Study in IgA Nephropathy: A Discrete Choice Experiment' on Oct. 5.
Study Type:
Observational
Primary Sponsor:
Institute - Otsuka Pharmaceutical Co., Ltd.
Condition:
Condition - IgA nephropathy
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To quantify the preferences of patients with IgA nephropathy and physicians involved in IgA nephropathy care in Japan for multiple treatment attributes and to determine the relative importance of these attributes.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
Gender - ...